Trial intelligence / Profile preview

Phase III Bronchitol in non-cystic fibrosis bronchiectasis

2005-005452-41Phase 3Completed

Sponsor
Pharmaxis
Start
Apr 2006
Modality
Small Molecules, Inhalation Devices → Device-based Delivery → Drug Delivery Systems
Countries
1
01

Overview

Phase 3, randomised, double-blind trial in bronchiectasis comparing Bronchitol with Placebo (2 arms). Primary endpoints: Change in St George's Respiratory Questionnaire score and 24-hour sputum sample. Started Apr 2006; status: completed.

02

Drugs

Bronchitol
03

Conditions

bronchiectasis

Beyond the preview

Go deeper on 2005-005452-41.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2005-005452-41.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call